ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674259 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674259; 2) Community: the network communities that were significantly associated with the response to NSC 674259; 3) Molecule: the relationships between components within communities and NSC 674259; 4) MDR: the compounds that were significantly associated with the NSC 674259.

NSC Compound Enrichment Correlation
NSC 720447 Null 0.0100967765290133 0.054356448
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0100967765290133 0.13076265
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0135588245836371 0.18145805
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0135588245836371 0.42841003
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0135588245836371 0.50283213
NSC 300289 Pinafide 0.0135588245836371 0.28956276
NSC 303861 L-Cysteine analog 0.0135588245836371 0.21146184
NSC 67091 Null 0.0135588245836371 0.27353788
NSC 683833 Null 0.0135588245836371 0.19947056
NSC 692332 Null 0.0135588245836371 0.3312265
Total:42  Current:10    [First] [Prev] [Next] [Last]